Therapeutic Effects of Rivastigmine and Alfa-Lipoic Acid Combination in the Charles Bonnet Syndrome: Electroencephalography Correlates

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|11|4|270-273

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.11, Iss.4, 2016-12, pp. : 270-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Seeing the unseen: Charles Bonnet syndrome revisited

By  

Psychogeriatrics, Vol. 15, Iss. 3, 2015-09 ,pp. : 204-208

John Wiley & Sons Inc

Access to resources Recommend Favorite

Levetiracetam: Exacerbation of Charles Bonnet syndrome in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1258, 2009-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

The therapeutic use of lipoic acid in diabetes: a current perspective

By Coleman M.D.   Eason R.C.   Bailey C.J.  

Environmental Toxicology and Pharmacology, Vol. 10, Iss. 4, 2001-09 ,pp. : 167-172

Elsevier

Access to resources Recommend Favorite

Physiological Effect and Therapeutic Application of Alpha Lipoic Acid

By  

Current Medicinal Chemistry, Vol. 21, Iss. 32, 2014-10 ,pp. : 3636-3645

Bentham Science Publishers

Access to resources Recommend Favorite

α-Lipoic acid: physiologic mechanisms and indications for the treatment of metabolic syndrome

By Pershadsingh Harrihar A  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 291-302

Informa Healthcare

Access to resources Recommend Favorite